In a mouse model of focal cerebral ischemia, the reduction of CBF in the infarction site was reversed by treatment with 3.0 mg/kg CBD through activation of the 5-HT1A receptor (Mishima et al., 2005). This evidence concerns the gene HTR1A and infarction.